If You Invested $10,000 in Amarin's IPO, This Is How Much Money You'd Have Now
Initial public offerings, or IPOs, usually garner lots of attention. IPOs carry tremendous amounts of risk, and trading publicly begins a new phase in the company's life. Drug development firms add in layers of additional risk -- clinical trial efficacy and safety risks, regulatory risk such as approval by the U.S. Food and Drug Administration (FDA), and reimbursement risk.